According to PetIQ's latest financial reports the company has HK$0.66 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | HK$0.90 B | 14.87% |
2022-12-31 | HK$0.79 B | 27.78% |
2021-12-31 | HK$0.61 B | 138.73% |
2020-12-31 | HK$0.25 B | 22.11% |
2019-12-31 | HK$0.21 B | -59.13% |
2018-12-31 | HK$0.51 B | 75.51% |
2017-12-31 | HK$0.29 B | 4878.02% |
2016-12-31 | HK$5.94 M | -76.39% |
2015-12-31 | HK$25.18 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
![]() Onconova Therapeutics ONTX | HK$0.12 B | -80.52% | ๐บ๐ธ USA |
![]() OPKO Health
OPK | HK$3.42 B | 418.24% | ๐บ๐ธ USA |